Pharmacodynamic Models for Agents that Alter Production of Natural Cells with Various Distributions of Lifespans
暂无分享,去创建一个
[1] H. Cramér. Mathematical methods of statistics , 1947 .
[2] E. Murphy,et al. The estimation of blood platelet survival. I. General principles of the study of cell survival. , 1969, Thrombosis et diathesis haemorrhagica.
[3] L. Sheiner,et al. A pharmacodynamic model of erythropoietin therapy for uremic anemia , 1992, Clinical pharmacology and therapeutics.
[4] H. Warnke,et al. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients , 1997, American journal of hematology.
[5] Lewis B. Sheiner,et al. Some suggestions for measuring predictive performance , 1981, Journal of Pharmacokinetics and Biopharmaceutics.
[6] Assessment of Dosing Impact on Intra-Individual Variability in Estimation of Parameters for Basic Indirect Response Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[7] W J Jusko,et al. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. , 1998, Journal of pharmaceutical sciences.
[8] M. Karlsson,et al. Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats. , 2000, The Journal of pharmacology and experimental therapeutics.
[9] A Schumitzky,et al. A program package for simulation and parameter estimation in pharmacokinetic systems. , 1979, Computer programs in biomedicine.
[10] A. Dornhorst. The interpretation of red cell survival curves. , 1951, Blood.
[11] M Kimmel,et al. Non‐parametric analysis of platelet lifespan , 1990, Cell and tissue kinetics.
[12] Dornhorst Ac. The interpretation of red cell survival curves. , 1951 .
[13] L. Harker,et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers , 2000 .
[14] H. Akaike. A new look at the statistical model identification , 1974 .
[15] R. Ramakrishnan,et al. Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells , 1999, Journal of Pharmacokinetics and Biopharmaceutics.
[16] W. Cheung,et al. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects* , 1998, Clinical pharmacology and therapeutics.
[17] R. Aster,et al. Platelet Kinetics: radioisotopic, cytological, mathematical and clinical aspects , 1972 .
[18] R. Ramakrishnan,et al. Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers , 2004, Journal of clinical pharmacology.
[19] M. Mackey,et al. Age-structured and two-delay models for erythropoiesis. , 1995, Mathematical biosciences.
[20] P. Bergner. On the stochastic interpretation of cell survival curves , 1962 .
[21] Varun Garg,et al. Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[22] Peter Veng Pedersen,et al. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[23] Murphy Ea,et al. The estimation of blood platelet survival. I. General principles of the study of cell survival. , 1969 .
[24] L. Harker,et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. , 2000, Blood.
[25] P. Berk,et al. Chapter 24 – The Biological Life of the Red Cell* , 1975 .
[26] B. Ridell,et al. On the analysis of platelet survival curves and the calculation of platelet production and destruction. , 2009, Scandinavian journal of haematology.
[27] F. Stohlman,et al. The kinetics of cellular proliferation , 1961 .
[28] A. M'Kendrick. Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.
[29] J. Widness,et al. An Integrated Pharmacodynamic Analysis of Erythropoietin, Reticulocyte, and Hemoglobin Responses in Acute Anemia , 2002, Pharmaceutical Research.
[30] E. Murphy,et al. The Estimation of Blood Platelet Survival II. The Multiple Hit Model , 1971, Thrombosis and Haemostasis.
[31] W. Jusko,et al. Population Cell Life Span Models for Effects of Drugs Following Indirect Mechanisms of Action , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[32] Kendrick,et al. Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.
[33] W. Jusko,et al. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[34] Douglas MacN. Surgenor,et al. The red blood cell , 1974 .